Company
Omniscient Neurotechnology
Omniscient Neurotechnology is a Sydney-based company specializing in AI-driven brain mapping solutions. Their Quicktome platform utilizes artificial intelligence to transform standard MRI scans into detailed brain network maps, aiding neurosurgeons and researchers in understanding brain connectivity for improved patient care. Founded in 2019, the company has expanded its reach to the United States, with an office in Wilmington, Delaware. Omniscient has secured significant funding, including a $27.2 million Series D round in May 2026, co-led by OIF Ventures and the Australian National Reconstruction Fund Corporation.
Investors
Investor